Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...

This dynamic landscape has driven the creation of a range of immune checkpoint-related products, encompassing high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits.

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

Korean researchers develop Trojan horse method to produce antibodies in tumors Innovative nanoparticle platform creates tumor ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

New research highlights a link between immune checkpoint inhibitors (ICIs) and an increased risk of autoimmune diseases, including rheumatoid arthritis, emphasizing the need for vigilance among ...

They block the binding of checkpoint proteins with their partner proteins, preventing the "off" signal that stops immune T cells from being activated. "Our research represents a remarkable ...